Skip to main content
Figure 2 | BMC Gastroenterology

Figure 2

From: Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients

Figure 2

DIMS0150 can enhance in vitro steroid sensitivity in steroid resistant UC patients. PBMCs from 9 steroid resistant UC patients and from 9 healthy volunteers were incubated for 48 hrs in the absence or presence of Dexamethasone and/or DIMS0150 and the expression levels analysed for (A) CD163, (B) TSP-1 and (C) IL-1RII. The P-values between two groups were calculated using unpaired t-test, the P-values inside a group were calculated using paired t-test.

Back to article page